health biotech news today obesity drugs glp-1 New Pill Foundayo (Orforglipron) Gets FDA Approval for The world's biggest health body
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for the treatment of type 2 diabetes and obesity, may modulate pathways associated with the hallmarks of aging
Will my insurance cover GLP-1 medications
A 2024 study suggests injectable semaglutide leads to more weight loss in real-world settings
What are the prior authorization requirements
Standard compounded semaglutide runs $249 a month after a $129 first month, billed at $747 every three months
These programs dont help uninsured patients but are game-changers for those with commercial insurance that denies coverage
